Skin Diseases, Infectious: Clinical Trials

1,560 trials for Skin Diseases, Infectious, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1005 completed, 167 unknown, 139 recruiting, 86 terminated. 408 Phase 2, 317 Phase 3, 293 Not applicable, 176 Phase 1, 133 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2408Completed 278, Unknown 34, Terminated 27, Recruiting 26, Active not recruiting 14, Not yet recruiting 13, Withdrawn 13, Suspended 2, Enrolling by invitation 1
Phase 3317Completed 221, Unknown 39, Active not recruiting 18, Terminated 17, Recruiting 11, Not yet recruiting 6, Withdrawn 4, Enrolling by invitation 1
Not applicable293Completed 171, Unknown 47, Recruiting 32, Not yet recruiting 19, Terminated 16, Withdrawn 6, Active not recruiting 2
Phase 1176Completed 134, Recruiting 11, Terminated 9, Unknown 7, Withdrawn 6, Not yet recruiting 4, Active not recruiting 2, Enrolling by invitation 2, Suspended 1
Phase 4133Completed 86, Recruiting 12, Terminated 12, Unknown 11, Not yet recruiting 9, Withdrawn 3
Early Phase 121Completed 8, Unknown 4, Withdrawn 4, Recruiting 3, Not yet recruiting 2

Follow Skin Diseases, Infectious: new trials by email Literature Review of Skin Diseases, Infectious trials Research Report on Skin Diseases, Infectious

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart
Phase 2SuspendedG&E Herbal Biotechnology Co., LTD1022030-09-012023-09-14
Assessment of the Prevalence of Rheumatic Heart Disease in School Settings in Mayotte and the Acquisition of Ultrasound Sequences Guided by Artificial Intelligence
Ultrasound performed bycardiologis for diagnosis of rheumatic heart disease - Rheumatic Heart Diseases, Scabies
Not applicableNot yet recruitingCentre Hospitalier Universitaire de la Réunion9002027-10-012026-10-29
A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes
ZYG24004 1% topical film-forming formulation, ZYG24004 3% topical film-forming formulation, Placebo topical formulation - Tinea Pedis
Phase 1RecruitingSinomune Pharmaceutical Co., Ltd642027-03-312026-11-19
A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
HZ Vaccine (IN001), Shingrix - Herpes Zoster
Phase 2Not yet recruitingShenzhen Shenxin Biotechnology Co., Ltd4802027-03-012026-11-18
Efficacy and Safety of Oral Ivermectin for Genital Warts
Ivermectin - Genital Warts
Not applicableNot yet recruitingUniversity of Health Sciences Lahore902027-02-202026-11-03
Comparison of Topical Permethrin 5% and Spinosad 0.9% for Scabies Treatment
Permethrin 5%, spinosad topical suspension, 0.9% - Scabies
Not applicableNot yet recruitingUniversity of Faisalabad1802027-02-012026-11-13
HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation
ivermectin infant formula preparation, Standard ivermectin 3mg tablet - Scabies
Phase 1SuspendedMurdoch Childrens Research Institute522027-01-012026-10-09
Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)
Sodium Stibogluconate (SSG), Miltefosine, Miltefosine + Paromomycin - Cutaneous Leihmaniasis
Phase 3Not yet recruitingInstitute of Tropical Medicine, Belgium9002027-01-012026-03-10
Immersive Technology Headsets to Reduce Procedural Pain and Anxiety: Feasibility and Effects in Cutaneous Leishmaniasis Patients in Pakistan
Virtual Reality - Cutaneous Leishmaniasis, Pain
Not applicableNot yet recruitingStanford University152027-01-012026-10-05
A Study of SL-325 in Participants With Hidradenitis Suppurativa
SL-325, Placebo - Hidradenitis Suppurativa (HS)
Phase 2Not yet recruitingShattuck Labs, Inc.1502027-01-012026-11-13
A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab
Hidradenitis Suppurativa
Not yet recruitingNovartis Pharmaceuticals342026-12-312026-11-10
Platform Trial for Salvage Consolidation Therapy in Dimorphic Fungi
Oteseconazole - Coccidioidomycosis, Blastomycosis
Phase 2Not yet recruitingUniversity of Minnesota302026-12-012026-09-04
Comparative Efficacy of Luliconazole and Bifonazole Combined With Itraconazole in Dermatophytosis
Itraconazole, Luliconazole Cream 1%, Bifonazole cream 1% - Tinea Corporis, Tinea Cruris
Phase 4Not yet recruitingUniversity of Faisalabad1822026-12-012026-11-12
Comparing Itraconazole Alone With Itraconazole Plus Terbinafine for Adults With Resistant Tinea Corporis
itraconazole, Itraconazole + terbinafine - Tinea Corporis, Resistant Dermatophyte Infection
Phase 2Not yet recruitingSheikh Zayed Medical College1042026-12-012026-11-20
Safety and Efficacy Study of SKX-16 in Participants With Mild to Moderate Distal Subungual Onychomycosis
SKX-16 (Luliconazole 10% Solution), Vehicle solution - Onychomycosis of Toenails
Phase 2Not yet recruitingSATO Pharmaceutical Co., Ltd.2042026-11-242026-11-10
A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients
Hidradenitis Suppurativa
Not yet recruitingNovartis Pharmaceuticals1862026-11-132026-10-20
Naproxen Versus Placebo as Adjunct Treatment of Cellulitis
enteric-coated naproxen, Cephalexin Tablets, Placebo - Cellulitis, Skin Disease, Infectious
Phase 3Not yet recruitingOttawa Hospital Research Institute8842026-11-012026-10-20
Early Pathophysiology of Hidradenitis Suppurativa and Prediction of the Risk of Progression: a Prospective Cohort
Biological samples and questionnaires, Analysis of residual skin tissue - Hidradenitis Suppurativa (HS)
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris2002026-11-012026-11-06
A Study to Explore the Tissue Level Effects of Remibrutinib in Adults With Moderate to Severe HS
LOU064, Placebo - Hidradenitis Suppurativa
Phase 1RecruitingNovartis Pharmaceuticals302026-10-292026-11-10
Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity
Olatorepatide, Placebo - Hidradenitis Suppurativa
Phase 2RecruitingRegeneron Pharmaceuticals3002026-10-292026-11-10

Showing 20 of 1560. Sign in to see all of them.

Narrower conditions

Hidradenitis Suppurativa (284)  ·  Herpes Simplex (159)  ·  Cellulitis (157)  ·  Onychomycosis (136)  ·  Warts (121)  ·  Condylomata Acuminata (113)  ·  Leishmaniasis, Cutaneous (103)  ·  Leishmaniasis (71)  ·  Tinea Pedis (70)  ·  Abscess (54)  ·  Herpes Labialis (52)  ·  Scabies (52)  ·  Skin Diseases (47)  ·  Uterine Cervical Neoplasms (45)

Broader conditions

Skin and Connective Tissue Diseases (1557)  ·  Infections (1520)  ·  Skin Diseases (1408)  ·  Bacterial Infections and Mycoses (743)  ·  Pathological Conditions, Signs and Symptoms (471)  ·  DNA Virus Infections (453)  ·  Virus Diseases (448)  ·  Skin Diseases, Viral (447)  ·  Suppuration (447)  ·  Bacterial Infections (433)  ·  Pathologic Processes (382)  ·  Skin Diseases, Bacterial (381)  ·  Dermatomycoses (288)  ·  Mycoses (281)

Interventions

Ivermectin (33)  ·  Acyclovir (31)  ·  Vancomycin (31)  ·  Terbinafine (30)  ·  miltefosine (29)  ·  Itraconazole (27)  ·  Valacyclovir (26)  ·  Meglumine Antimoniate (23)  ·  Linezolid (19)  ·  Cryotherapy (18)  ·  Adalimumab (16)  ·  Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (16)  ·  Permethrin (15)  ·  secukinumab (14)  ·  Azithromycin (13)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (46)  ·  GlaxoSmithKline (34)  ·  Novartis Pharmaceuticals (30)  ·  Merck Sharp & Dohme LLC (24)  ·  Pfizer (23)  ·  Sun Pharmaceutical Industries, Inc. (18)  ·  AbbVie (17)  ·  Assiut University (16)  ·  U.S. Army Medical Research and Development Command (16)  ·  Incyte Corporation (12)  ·  Shanghai Bovax Biotechnology Co., Ltd. (12)  ·  Assistance Publique - Hôpitaux de Paris (11)  ·  Institute of Tropical Medicine, Belgium (11)  ·  Combined Military Hospital Abbottabad (10)  ·  Drugs for Neglected Diseases (10)

Countries

United States (636)  ·  Canada (122)  ·  Germany (110)  ·  France (93)  ·  Spain (79)  ·  China (75)  ·  Poland (63)  ·  United Kingdom (60)  ·  Australia (57)  ·  Brazil (53)  ·  Italy (53)  ·  Netherlands (52)  ·  Belgium (45)  ·  Pakistan (43)  ·  Greece (41)

Top investigators

G. Ralph Corey, MD (6)  ·  Hadar Lev-Tov, MD (5)  ·  Jun Zhang, Master (5)  ·  Connie Celum, MD, MPH (4)  ·  Gary Weil, MD (4)

Results publications

PMID 32184277, PMID 41276263, PMID 19236277, PMID 19236279, PMID 19935017, PMID 27422279, PMID 27518661, PMID 28379954, PMID 29380251, PMID 30597021, PMID 30716446, PMID 30982556, PMID 31604104, PMID 34741280, PMID 34905144, PMID 34922058, PMID 36746171, PMID 41166720, PMID 41248770, PMID 42482599, PMID 42525209, PMID 15897380, PMID 17845167, PMID 18444791, PMID 19095213, PMID 20346539, PMID 20695801, PMID 20949623, PMID 21115456, PMID 21471141, PMID 21991950, PMID 22236226, PMID 22416054, PMID 22454089, PMID 23066159, PMID 23247938, PMID 23299013, PMID 23336207, PMID 23632723, PMID 23877689, PMID 24897082, PMID 25007364, PMID 25273231, PMID 26343451, PMID 27370913, PMID 27585969, PMID 28630189, PMID 29074187, PMID 29211620, PMID 29214505

NIH funding

2023 (11), 2025 (9), 2008 (6), 2018 (6), 2019 (5), 2015 (4), 2004 (3), 2014 (3), 2017 (3), N01AI30025 (3), U19AI065866 (3), 2009 (2), 2016 (2), P01AI030731 (2), I50HX002263 (1)